RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A - Wikidata - awgldk - TriplyDB

RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A

RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A

http://www.wikidata.org/entity/Q36730389

about

Dinosaurs and ancient civilizations: reflections on the treatment of cancer Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia Neoplasia: the second decade.Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.The NF1 somatic mutational landscape in sporadic human cancers.Neoplasms associated with germline and somatic NF1 gene mutations The NF1 gene revisited - from bench to bedside.Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth.BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas.Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations Loss of RASSF1A expression in colorectal cancer and its association with K-ras status.JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context.Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.The War on Cancer rages on.Colorectal cancer and RASSF family--a special emphasis on RASSF1A.RAS signaling pathways, mutations and their role in colorectal cancer DNA methylation and apoptosis resistance in cancer cells Valproic acid enhances bosutinib cytotoxicity in colon cancer cells.Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.Association between clinicopathological characteristics and RAS mutation in colorectal cancer.BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.A robust targeted sequencing approach for low input and variable quality DNA from clinical samples.An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer.Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.Overexpression of ST5, an activator of Ras, has no effect on β-cell proliferation in adult mice.

P2860

Q24628746-A490FA17-2EEA-4AB6-8C95-3E8A58311A8E Q26795609-A6FD804D-6535-4E37-9F82-2E48DABEEAE6 Q26828992-C51A2514-9AEB-45BE-BE42-3AF5C325AAE5 Q28485464-50E142B1-05FD-4559-9614-548699A00A6F Q28546078-EB133038-6DA2-4EC9-A8C5-774432C13853 Q30484000-8FD1515F-7D85-440F-9D18-4E5F5C7F8283 Q33729779-687A5579-AA0E-42F9-A131-BC0053C71841 Q33754380-C7BFD6FE-6119-41F3-9CFB-409C54E40391 Q33823452-922AAB3F-866A-4C06-AEFE-1BE36682A9FB Q34125947-67796F6F-89E7-4373-A120-28F5D5BD9876 Q34227509-39DD58D6-4667-4CE3-9D4F-E8063016227F Q34273969-DD159FCE-1383-4C03-BEFB-059168002523 Q34277852-9ECD5B1D-87FF-4169-A605-23BB27AFAEA2 Q34621860-2C9E0B65-5A55-40B8-87C5-415BE7B2EB76 Q35130874-CB876F60-E459-446F-A10C-39C29F2B8AD4 Q35428487-F889FACB-EAD8-44E9-BABC-DF442FC02E2A Q35447606-5FE8DE21-191B-4A04-971F-4B9F0F3E3190 Q36822387-079CABE1-97A4-45A5-BA38-1A4D151063A1 Q36982106-BD2B4130-1D5E-4DD2-8BBD-3B7E49CD4082 Q36995731-2222A817-2592-48A9-B091-1F64DC44E55E Q37021811-94373B19-9874-44DB-A626-D7B3388E4301 Q37040359-F69295DC-4EAF-421E-B382-F53E68315C6D Q37091263-4FA4F4B1-0851-460A-B380-9527A03CC458 Q37165838-375441DC-B3FE-4D6F-8171-D00896EA7248 Q37478602-D586C1F0-FF7C-4A6E-9B26-3BC5DB6B9779 Q38021701-FCFF71BB-3DF7-4869-80B9-5EDCE52D6963 Q38116869-1549A4F2-9E86-41D1-BFFB-EDA49BBA5D25 Q38202821-1E4D6F21-AA91-48E0-8CC3-76438E24E4E7 Q39898672-89B77603-659F-4F43-ABAE-E3453FD9F2BC Q41582116-1FAE521D-8B44-4A19-BEF3-534B9E98DC01 Q42719109-F76FC06F-2D2A-42CC-BCEF-3B3B7891F6F8 Q48010330-AA4CB732-DB53-4646-877A-FBBF4D7FBA20 Q48731798-9313B004-4DDE-4A01-9B69-7DA4DB067E84 Q49205689-1618E941-4D07-4B73-BBDF-83F4980FECDC Q53490424-E58E35B5-0DE1-448C-BC14-9F8814ADEC37 Q54500317-E3DBC2FE-E1AF-43C5-B2F7-D067C837E21E Q54614277-D37FC25E-4FA4-40B9-BB86-EB1D3A841C00 Q54709996-E9CF1A1D-FF8C-447E-A720-2C4F4DC58FD2 Q55078845-F6929074-41BE-4692-BFA4-CCB042C3E311

P2860

RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A

http://www.wikidata.org/entity/Q36730389

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@ast

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@en

type

label

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@ast

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@en

prefLabel

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@ast

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@en

P1433

Q36730389-74D0AB97-E51B-4B4C-9AFC-65126C23E092

P1476

Q36730389-2EC62968-BF98-4BF0-90A8-3F83EF15306A

P2093

Q36730389-6287E1CF-A88C-42BD-9523-3DC3B120EFB2

Q36730389-6BCACEA2-8932-45B4-8A79-DAB7207EC6CD

Q36730389-7796B541-3C2F-496E-966A-6CDBE401236A

Q36730389-7C0731E4-6929-47FF-902A-58A9E0974CCE

Q36730389-8AF3967E-5096-4616-BE30-4B6644D27B9F

Q36730389-CBB26DED-61C7-4CB8-85FB-1E695DA39B48

P2860

Q36730389-10658C0A-EF80-486B-8918-071C810FE245

Q36730389-11B7A667-E97D-4BFB-A226-713C7A7043FC

Q36730389-130D5FCF-2210-426A-BAEE-B8A17AE1F830

Q36730389-1BE9F38D-6C93-4F28-9C35-FE77A27AB70B

Q36730389-1E294020-CF1D-45FC-B124-324759C8BF38

Q36730389-2105D84F-DA5B-4F0A-9BC8-8BA3C8B98755

Q36730389-25A2B4FB-5C1A-479E-A34A-01513E1ACB9C

Q36730389-287FFA8C-78F0-4FFF-93CC-D501E62047BB

Q36730389-4B6A7CFC-FFDC-4DB8-815B-C3FF0EE88C45

Q36730389-4EF9909D-B7A5-492C-982A-02BD3539FFCA

P304

Q36730389-6BA0442C-95CB-4527-8B1F-2E4BDF14AA0D

P31

Q36730389-3B5756E6-14BF-4D67-9B8D-3F1F58B658BB

P356

Q36730389-8D20CB98-09F0-470B-AEC3-3516265F851F

P433

Q36730389-5D62CC66-18AA-4318-94ED-44FD30AAF9CA

P478

Q36730389-13FDFFA7-7BA6-4F82-9D7E-075AC9FB6426

P50

Q36730389-11FC6DA9-34E9-4395-A7FD-C6D687C8EED4

Q36730389-A13C3826-1A41-426C-B2E8-F99835CB8547

P577

Q36730389-E3FCF6D4-8C10-478F-B568-D5F3530D7947

P5875

Q36730389-DDD998A9-7A4C-4267-8433-C55974FB9B9B

P698

Q36730389-9F7348A1-4B40-4BCD-B387-FBE20A8F1488

P932

Q36730389-5C44C5A3-E658-4334-80BA-0C3F818E362C

P356

P1433

P1476

RAS signaling in colorectal ca ...... RAS, RAF, NF1, and/or RASSF1A

@en

P2093

Gunn I Meling

http://www.w3.org/2001/XMLSchema#string

Guro E Lind

http://www.w3.org/2001/XMLSchema#string

Irene Bottillo

http://www.w3.org/2001/XMLSchema#string

Stine A Danielsen

http://www.w3.org/2001/XMLSchema#string

Terje Ahlquist

http://www.w3.org/2001/XMLSchema#string

Torleiv O Rognum

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Somatic mutations in the neurofibromatosis 1 gene in human tumors

Characteristic promoter hypermethylation signatures in male germ cell tumors

Mutations of the BRAF gene in human cancer

NF1 tumor suppressor gene function: narrowing the GAP

The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21

MAP kinase signalling pathways in cancer

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

P304

680-6, 2 p following 686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.08312

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ragnhild A. Lothe

Bruno Dallapiccola

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5261569

http://www.w3.org/2001/XMLSchema#string

P698

18592002

http://www.w3.org/2001/XMLSchema#string

P932

2434205

http://www.w3.org/2001/XMLSchema#string